Skip to main content
Log in

Aerosol Dispersion of Respirable Particles in Narrow Size Distributions Using Drug-Alone and Lactose-Blend Formulations

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To examine the effect of formulation type on the aerosolization of respirable particles in narrow size distributions.

Methods. Aerosol dispersion of two formulation types (drug alone and 2% w/w drug-lactose blends) containing micronized or spray-dried fluticasone propionate (FP) particles (d50% = 1.3 to 9.6 μm, GSD = 1.8 to 2.2) were examined using cascade impaction at 60 L/min with low and high resistance inhaler devices: Rotahaler and Inhalator, respectively.

Results. The aerosol dispersion of FP particles was significantly affected by the particle size, particle type, inhaler device, and formulation type. Interactions were observed between all factors. Generally, greater powder entrainment was obtained with smaller d50%. Higher emitted doses were obtained from drug-alone formulations of spray-dried FP particles and lactose blends of micronized FP particles. Greater aerosol dispersion of spray-dried FP particles was obtained using lactose-blend formulations with d50% around 4 μm. Greater aerosol dispersion of micronized FP particles was obtained using formulations of drug alone. Larger d50% produced larger mass median aerodynamic diameters.

Conclusions.Small changes in the particle size within the 1-10-μm range exerted a major influence on aerosol dispersion of jet-milled and spray-dried FP particles using drug-alone and lactose-blend formulations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. P. R. Byron. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J. Pharm. Sci. 75:433-438 (1986).

    Google Scholar 

  2. N. Chew and H.-K. Chan. Influence of particle size, air flow and inhaler device on the dispersion of mannitol powders as aerosols. Pharm. Res. 16:1098-1103 (1999).

    Google Scholar 

  3. N. Y. K. Chew, D. F. Bagster, and H.-K. Chan. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int. J. Pharm. 206:75-83 (2000).

    Google Scholar 

  4. M. D. Louey, M. Van Oort, and A. J. Hickey. Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques. Pharm. Res.

  5. N. M. Kassem, K. K. L. Ho, and D. Ganderton. The effect of air flow and carrier size on the characteristics of an inspirable cloud. J. Pharm. Pharmacol. 41:14P(1989).

    Google Scholar 

  6. M. A. Braun, R. Oschmann, and P. C. Schmidt. Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the twin impinger. Int. J. Pharm. 135:53-62 (1996).

    Google Scholar 

  7. H. Steckel and B. W. Müller. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int. J. Pharm. 154:31-37 (1997).

    Google Scholar 

  8. N. M. Kassem and D. Ganderton. The influence of carrier surface on the characteristics of inspirable powder aerosols. J. Pharm. Pharmacol. 42:11P(1990).

    Google Scholar 

  9. Y. Kawashima, Takanori Sarigano, Tomoaki Hino, Hiromitsu Yamoto, and Hirofumi Takeuchi. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int. J. Pharm. 172:179-188 (1998).

    Google Scholar 

  10. D. Ganderton. The generation of respirable clouds from coarse powder aggregates. J. Biopharm. Sci. 3:101-105 (1992).

    Google Scholar 

  11. P. Lucas, K. Anderson, and J. N. Staniforth. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm. Res. 15:562-569 (1998).

    Google Scholar 

  12. X. M. Zeng, Xian Ming Zeng, Gary Peter Martin, Seah-Kee Tea, and Christopher Marriot. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro. Int. J. Pharm. 176:99-110 (1998).

    Google Scholar 

  13. A. J. Hickey and N. M. Concessio. Flow properties of selected pharmaceutical powders from a vibrating spatula. Particle and Particle Systems Characterization (11):457-462 (1994).

    Google Scholar 

  14. T. M. Crowder and A. J. Hickey. An instrument for rapid powder flow measurement and temporal fractal analysis. Particle and Particle Systems Characterization (16): 32-34 (1999).

    Google Scholar 

  15. I. Gonda. Targeting by deposition. In A. J. Hickey (ed.), Pharmaceutical Inhalation Aerosol Technology, Marcel Dekker, Inc., New York, 1992, pp. 61-82.

    Google Scholar 

  16. W. C. Hinds. Uniform particle motion. In Aerosol Technology. Properties, Behavior, and Measurement of Airborne Particles, Wiley-Interscience, New York, 1982, pp. 38-68.

    Google Scholar 

  17. B. H. Kaye. A Random Walk Through Fractal Dimensions, VCH Publishers, Weinheim, 1989.

    Google Scholar 

  18. A. R. Clark and A. M. Hollingworth. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers—implications for in vitro testing. J. Aerosol Med. 6:99-110 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony J. Hickey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Louey, M.D., Van Oort, M. & Hickey, A.J. Aerosol Dispersion of Respirable Particles in Narrow Size Distributions Using Drug-Alone and Lactose-Blend Formulations. Pharm Res 21, 1207–1213 (2004). https://doi.org/10.1023/B:PHAM.0000032991.74736.3e

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAM.0000032991.74736.3e

Navigation